Cogent Biosciences Inc (COGT) Directors and Executive Officers

Officers & Directors

Todd Shegog
Director

Chris Cain
Director

Matthew Ros
Director

Andrew Robbins
Chief Executive Officer, President, and Director (Principal Executive Officer)

John Green
Chief Financial Officer (Principal Financial and Accounting Officer)

Peter Harwin
Director

Arlene Morris
Director

Karen Ferrante, M.D.
Director ,

Cogent Biosciences Inc currently has 258 employees.

News about Cogent Biosciences Inc Key Personnel

Cogent Biosciences: Navigating Financial Turbulence While Pioneering Breakthroughs in Cancer Therapy

As the biotech sector grapples with economic headwinds, Cogent Biosciences Inc. stands at a pivotal juncture in its mission to advance targeted therapies for cancer. Despite its cumulative net loss of $242 million over the past year, the company is forging ahead with ambitious milestones for its lead drug, Bezuclastinib, and its new portfolio of selective therapeutics. In a recent announcement, Cogent disclosed it plans to report top-line results from the registration-directed SUMMIT trial in patients with Non-Advanced Sys-temic Mastocytosis (NonAdvSM) by July 2025. This trial is part of the company’s broader strategy to establish its foothold in a competitive market while addressing the unmet needs of pat...